SGLT2 Inhibitor Therapy and Risk of Incident Atrial Fibrillation in Patients With HFpEF and Type 2 Diabetes
Year: 2026
Type: article
Study design: Observational Study
Source: Cardiology
DOI: 10.1159/crd/absag026
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7221999018
FWCI:
Cites:
Cited by:
Related to:
